evid procedur recoveri
near-term pressur clear stock recoveri like
follow phase recoveri path capital-expenditure trend remain
least visibl expect signific pressur balanc
dynam evid procedur recoveri strong
littl surpris regard quarter result broadli in-lin
expect given last week system procedur growth pre-
announc see note gross net system placement
rel durabl primarili reflect strong order book
enter year fulfil quarter leas rate fell pt
sequenti revers recent upward trend due select larg purchas
order continu see leas trend higher time perhap
spike near-term given induc hospit pressur ion system
sp system place quarter vs mse respect
system place china japan europ prior covid-
intuit fundament trend higher procedur growth
approach enter estim like sustain rate
januari februari march debat clearli shift
away tradit quarterli driver
procedur insul recoveri certain procedur prove
emerg vs other within quarter includ oncolog thorac
colorect surgeri meanwhil hernia repair benign gynecolog bariatr
sever impact march global benign procedur roughli
intuit mix ex-u oncolog procedur greater proport
overal mix china like even skew averag ex-u
number view may drive greater resili look forward overal
procedur exit march vs prior run-rat adjust
procedur toward bear estim mani compani
see origin base-to-bear framework model
recoveri consist corpor abbott also echo
medic technolog unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
comment morgan stanley china research colleagu
host march see takeaway colleagu estim
inpati volum return pre-covid level china exit
march expect elect procedur return normal april-
end abbott indic yesterday diagnost test return
normal china intuit supplementari chart suggest china
improv consist w/w past week approach
normal seeexhibit
exhibit intuit china procedur approach normal
capital-expenditure similar recent discuss expect
driven capital-expenditure impact see math capital-expenditure note
unlik strain hospit coupl challeng credit
environ crisi front us access issu white
hous new open america plan may present resolut
howev impact acut access issues- evid date- hospit
cash flow suggest capit trough like deeper time access
improv could see sharper bounc expect ultim durat
capital-expenditure recoveri elong period seen
financi crisi exhibit regard competit recent
highlight soft tissu launch like behind investor
appreci mse environ posit
intuit also creat challeng sell environ new entrant
intuit ceo suggest recess impact differ
financi crisi sever way importantli intuit
today visibl grow backlog procedur case
although time recoup remain uncertain
intuit face steeper awar adopt curv capit constraint
drove increment greater challeng bring new hospit
intuit network vs sell increment system larg familiar custom
today rel posit withstand europ placement
declin y/i like instruct current forward us
placement trend overal quarterli number suggest see
signific risk system placement intermedi term
exhibit intuit surgic peer devic capit sale prior
model chang frequent discuss import consid
base bear case origin impact framework see
point recent toward bear
probabl outcom earn commentari support approach
intuit adjust model accordingli model
revenu previous base da vinci placement
procedur declin vs placement declin previous
model total revenu previous
base da vinci placement procedur declin vs
placement declin previous assum margin drop
oper margin revenu lost
arriv ep ep expect downward
revis street ep estim consensu today ep
unlik mani peer expect intuit spend aggress
cycl given balanc sheet posit corpor philosophi
intuit like recov behind phase maintain long-term
posit bia mid-februari outlin origin roadmap
assign defensive/ diversifi insul compani phase
assign elective-procedur expos name cardio
neuromod implant phase continu expect capital-ori
name includ intuit like outperform part phase
later recoveri cycl perform to-dat broadli consist
expect though see intuit continu lag other
timelin given capital-expenditure exposur intuit also maintain one strongest
balanc sheet across coverag cash invest
could becom increas perform driver econom impact
worsen importantli remain confid intuit
technolog market leadership robot surgeri long-term
compani abil expand remain overweight updat
price base dcf model assum wacc
termin growth rate long-term oper margin
million except ep
interest incom expens
sale
sale
sale
sale
sale
sale
price target base discount cash ow model
assum wacc termin growth rate long-term oper margin
given capit exposur intuit
lag insul devic peer
near term later
recoveri opportun
out-performance longer term
fundament remain robust
beyond margin sustain
low
pipelin expand sp
system open natur oric
singl incis market ion system
open endolumin market
primari focu lung biopsi
thomson reuter morgan stanley research morgan stanley institut equiti divis probabl
bull base bear case scenario play estim impli volatil data option market
apr gure approxim risk-neutr probabl stock reach beyond scenario price
either three-month one-year time view explan option probabl methodolog
view descript risk reward theme
procedur recov covid-
system placement impact better
fear longer term gener surgeri ex
us procedur acceler adopt
gener surgeri ex us geographi two
larg under-penetr market pick
drive sustain
dcf-base support base
impact expand
procedur declin materi sever
quarter due system
throughout competit
intensi earlier expect visibl
toward product offer launch time
concern investor pressur growth
us hernia nearli total procedur
drive pt procedur growth
pt procedur growth
ion sp adopt
china india
view explan region hierarchi
research highest favor quintil
impact procedur system
placement less materi fear
intuit continu grow higher
rate expect
ion sp adopt ramp quickli
constrain hospit capital-expenditure
competit cmr
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
dollar million except per share data
good sold
interest incom
net incom attribut
dollar million except per share data
invest
long-term debt net defer tax
treasuri
accumul comprehens
dollar million except per share data
loss sale plant equip
net chang work capit
prepaid expens ca
chg invest secur
net invest
chg short-term debt
chg long-term debt
chang equiti
net financ
effect exchang rate chang
begin period
end period
